Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I

Although DNA-based cancer vaccines have been successfully tested in mouse models, a major drawback of cancer vaccination still remains, namely that tumour antigens are weak and fail to generate a vigorous immune response in tumour-bearing patients. Genetic technology offers strategies for promoting...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cuesta, Ángel M, Suárez, Eduardo, Larsen, Martin, Jensen, Kim Bak, Sanz, Laura, Compte, Marta, Kristensen, Peter, Álvarez-Vallina, Luis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2006
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1782252/
https://ncbi.nlm.nih.gov/pubmed/16556264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2567.2006.02325.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak